Until now there has not been an industry standard for clinical research auditing, but CRO Pharm-Olam and IAOCR have addressed that. Pharm-Olam developed a 12-week program, Core Global Competencies for Clinical Research Auditing, which IACOR has independently accredited to ensure consistently high standards of clinical research auditing across the industry. Individuals will be designated as Internationally Qualified Clinical Research Auditors, designated letters of AIACR. Pharm-Olam is funding the program for qualified members of its vendor network; however, the program is available to all individuals to gain the professional status.
For more information, click here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.